Companies › FBIO
FORTRESS BIOTECH INC (FBIO)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001429260 · EDGAR filings · Updated 2026-06-24
FORTRESS BIOTECH INC (FBIO) has reported institutional ownership of 16.1%, with 51 institutional managers holding positions valued at $14.9M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-06-24 — Insider transaction reported (Form 4)
- 2026-06-23 — Current report (8-K) filed
- 2026-05-15 — SCHEDULE 13G/A filed
- 2026-05-14 — Quarterly report (10-Q) filed
- 2026-05-14 — Current report (8-K) filed
- 2026-04-28 — DEFA14A filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, FORTRESS BIOTECH INC has 51 institutional holders and institutional ownership of 16.1%.
Insider activity
Insiders reported 9 transactions (0 buys, 0 sells) across 8 reporting insiders, with a net reported value of $0.
Data flags from SEC filings
Related companies
GAIN THERAPEUTICS INC (GANX) · SENSUS HEALTHCARE INC (SRTS) · Hyperfine Inc (HYPR) · REIN THERAPEUTICS INC (RNTX) · NEURAXIS INC (NRXS) · PARK DENTAL PARTNERS INC (PARK)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-24.